Impact of apremilast on quality of life in Behcet's syndrome: analysis of the phase 3 RELIEF study

Creative Commons License

Hatemi G., Mahr A., Takeno M., Kim D., Melikoglu M., Cheng S., ...More

RMD OPEN, vol.8, no.2, 2022 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 8 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.1136/rmdopen-2022-002235
  • Journal Name: RMD OPEN
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Keywords: Behcet Syndrome, Systemic vasculitis, Patient Reported Outcome Measures, DISEASE-ACTIVITY, RELIABILITY, VALIDITY, SF-36
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: Yes

Abstract

Objective To assess apremilast's impact on patient quality of life (QoL) in active Behcet's syndrome and correlations between improvement in patients' QoL and efficacy measures in the phase 3 RELIEF study.